DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactStocks

Stock Picks Today: Swiggy, SRF, Colgate, Cyient, And More On Brokerages' Radar

NDTV Profit 1 hr ago·23 Oct 2026, 1:36 am

Brokerages have placed SRF on their radar, suggesting the specialty chemicals and packaging manufacturer could be a focus for investors today. The company is a key player in the high-growth FMCG and pharmaceutical sectors, making it a stock that often attracts attention due to its consistent earnings and strong market position. For investors, this spotlight indicates that analysts are closely monitoring the company's performance and future outlook.

Investors should pay attention to the broader market sentiment and any specific commentary from brokerage reports regarding SRF's operational efficiency and demand in key markets. While the stock is under review, it is essential to evaluate the broader economic factors that could impact the chemical industry before making any investment decisions.